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Summary Restriction fragment length polymorphism (RFLP) of the L-myc gene was examined in DNAs
from primary tumour tissues and peripheral blood cells (PBC) of 76 Indian patients with squamous cell
carcinoma of the oral cavity, and PBC from 101 normal healthy volunteers. The patients and the normal
healthy volunteers were classified into three genetic types according to the polymorphic patterns defined by the
two alleles (6.6 kb, S fragment; and 10.0 kb, L fragment). DNA isolated from the PBC of each patient always
exhibited the same pattern of L-myc alleles as that observed for the corresponding tumour DNA. However, a
striking correlation was found between the RFLP pattern and the stage of differentiation of the tumours, as
well as the size of the tumour. Thus, a preponderance of the S fragment was observed in the poor to
moderately differentiated tumours and the larger (>4 cm) sized tumours. Further, analysis of L-myc RFLP
with the clinical pattern of the malignancy showed no significant correlation with nodal metastasis, TNM
staging or recurrence of the tumour. The relative ratios of the three genotypes (L-L, L-S, S-S) in the oral
cancer patients were not significantly different from those seen in the healthy Indians, implying no predisposi-
tion to oral cancer by either allele. However, our results showed that oral cancer patients with a genotype
including an S fragment are more likely to develop a poor to moderately differentiated tumour or a larger
tumour than a patient without an S fragment. The L and S alleles were equally distributed in the population,
with the frequency of each allele being 0.50, consistent with Hardy-Weinberg's law.
Human oral cancer is a major cause of mortality in Third
World countries, comprising 40-50% of all malignancies in
several parts of India and South East Asia (Pindborg, 1984;
Sanghavi, 1981). The tumour is relatively uncommon in the
Western society, constituting 2-5% of all malignancies
(Field & Spandidos, 1987). On the Indian scene,
epidemiological and experimental evidence has indicated a
causal relationship between chewing tobacco and oral cancer,
tobacco being the 'sine qua non' of oral cancer (Gupta et al.,
1988; Jussawalla & Deshpande, 1971). However, there is a
paucity of information on the molecular basis of cancer of
the oral cavity and the involvement of oncogenes, which have
been implicated in several human tumours, in oral cancers.
Recent studies from our laboratory have demonstrated the
involvement of oncogenes in squamous cell carcinoma of the
oral cavity, via amplification of myc and ras family genes
(Saranath et al., 1989). A 5-10-fold amplification of Ki-ras
was reported in 17% and 30%, respectively, of the oral
cancer samples investigated. Of the three well defined myc
family oncogenes, we observed c-myc and N-myc amplified in
20-40% of the primary tumour tissues examined, whereas
L-myc was not amplified in any of the samples.
RFLP studies of the L-myc gene have demonstrated a
close association of the S (6.6 kb) fragment with metastatic
potential in lung cancer (Kawashima et al., 1988), colon and
stomach cancers (Kawashima et al., 1987), and renal cell
carcinomas (Kakehi & Yoshida, 1989). These studies
indicated that the L (10.0kb) fragment was an indicator of
better prognosis in the cancers. Further, Kawashima et al.
(1987) observed an increased frequency of the L fragment in
normal somatic cells of colon tumour patients as compared
to normal individuals, thus implying the presence of the L
allele as an indicator of genetic predisposition to colon
tumours. In this study, we have investigated the prognostic
utility of L-myc polymorphic fragments in oral cancers, and
the correlation between L-myc RFLPs and the clinical pat-
tern of squamous cell carcinoma of the oral cavity, in the
Indian population.
Material and methods
Subjects
Seventy-six untreated patients (57 males, 19 females, aged
20-70 years), diagnosed as having squamous cell carcinoma
of the oral cavity, were studied for L-myc RFLP. The diag-
nosis was based on clinical examination and histological
features of the biopsy material. The various sites included:
buccal mucosa, 34 patients; tongue, 19 patients; lower
alveolus, 21 patients; and floor of the mouth, two patients.
The tumour tissues were resected near the advancing edge of
the tumour, avoiding the more necrotic central region.
Peripheral blood cells (PBC) were collected from the oral
cancer patients on admission to the surgical ward of Tata
Memorial Hospital. PBC were also obtained from 101 nor-
mal healthy volunteers, and used as controls to determine
frequency of the L-myc alleles in the normal population.
More than 80% of the patients as well as the normals
belonged to the Hindu community. Samples were frozen in
liquid nitrogen until isolation of DNA. For the analysis,
samples were serially coded irrespective of the
clinicopathological status of the patient.
DNA extraction
DNA was extracted from the carcinoma samples, PBC of the
cancer patients and PBC of normal controls, according to the
standard method (Maniatis et al., 1982).
Human L-myc probe
The 1.8 kb human L-myc Smal-EcoRI fragment, used as a
probe, was prepared from recombinant plasmid (PJB327)
containing the fragment; the plasmid, a gift from J.D.
Minna, National Institute of Health, USA (Nau et al., 1985),
was obtained through G. Klein, Karolinska Institute, Stock-
holm, Sweden. The 1.8 kb L-myc fragment was purified by
preparative agarose electrophoresis using low melting
agarose. The probe was labelled by a2P dCTP to a specific
activity of more than 108 c.p.m. fig-', according to the
method of Feinberg and Vogelstein (1983).
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Southern analysis
Genomic DNAs (labelled numerically) were digested to com-
pletion with the restriction endonuclease EcoRI, under stan-
dard conditions. Ten gLg of the digest was subjected to elec-
trophoresis on 0.7% agarose gels in 89 mM Tris-borate,
89 mM boric acid and 2 mM EDTA buffer at pH 8.0.
Denatured DNA fragments were blotted onto a nylon mem-
brane (Hybond-N, Amersham) according to standard proce-
dure, as described by Southern (1975).
Hybridisation, washing and autoradiography were carried
out as previously described (Saranath et al., 1989). Hind III
digested A DNA was used as size marker.
Results
L-myc RFLP patterns in oral cancers
L-myc RFLP data on EcoRI digested DNA isolated from
primary tumour tissue samples of 76 oral cancer patients and
normal healthy volunteers (101 samples) examined by
Southern blot analysis are given in Table I, and represen-
tative Southern blots are shown in Figure la and b. Sixteen
patients were genetically homozygous for the 10kb L-myc
fragment (L-L type), 23 were homozygous for the 6.6 kb
fragment (S-S type) and 37 were heterozygous (L-S type).
DNA isolated from the PBC of each patient exhibited the
same pattern of the L-myc alleles as that observed for the
corresponding tumour DNA. PBC DNAs from 101 healthy
volunteers exhibited the three haplotypes, with 30 samples
L-L type, 22 S-S type and 49 L-S type (Table I). The relative
ratios of the L-L, L-S and S-S fragments in the oral cancer
patients were not significantly different from those observed
in the 101 healthy individuals (X2 = 2.47, d.f. = 2, P<0.25).
In the total population studies (i.e. cancer patients plus con-
trols) the genotype L-L was observed in 46/177 (25.9%), L-S
in 86/177 (48.5%) and S-S in 46/177 (25.9%) individuals.
Thus the two alleles L and S were equally distributed in the
population, with the frequencies of the S and L alleles each
being approximately 0.50.
Correlation ofL-myc RFLP with clinicalpattern
The relationships between L-myc RFLP and the level of
differentiation, nodal metastasis, size of the primary tumour
and TNM staging (UICC, 1988), at the time of surgery for
the primary tumour are summarised in Table II. The L-myc
RFLP pattern was noted in the numerically labelled samples,
and the data were compiled according to the clinical
parameters. Of the 51 patients with poor to moderately
differentiated tumours, 48 (94%) had either the L-S or S-S
type pattern. X2 analysis revealed that the S fragment present
as the L-S or S-S type pattern was significantly increased in
poor to moderately differentiated oral tumours compared
with well differentiated tumours (12/25 = 48%) (X2 = 18.8,
d.f. = 1, P<0.001). The relationship between tumour size
Table I Distribution ofL-myc RFLP pattern, and allele frequencies of
the L-myc gene in tumour tissues and PBCI of oral cancer patients
Tumour tissues Peripheral blood cells
or oral Oral cancer Normal healthy
RFLP cancer patients patients volunteers
patter (76 cases) (76 cases) (101 cases)
L-L 16 (21)b 16 (21) 30 (29.7)
L-S 37 (48.6) 37 (48.6) 49 (48.5)
S-S 23 (30.4) 23 (30.4) 22 (21.7)
Allele frequenciesc
L 0.45 0.45 0.54
S 0.55 0.55 0.46
Kb
10.0-4
&.6'-
U.
b
Kb 123 .4 5 .6 7 8 9 10 11 12 13
Figure I a, Southern blot analysis of primary tumour tissue
DNA from oral cancer patients (numbered), digested with EcoRI
(10ig DNA was loaded in each lane). The arrows indicate
10.0 kb (L) and 6.6 kb (S) L-myc specific fragments. b, The
samples from normal healthy volunteers.
and the presence or absence of the S fragment indicated an
association of the S fragment with larger sized tumours
(x2 = 5.75, d.f. = 1, P<0.025). The S fragment was present in
46/54 (85%) of the larger (>4cm) tumours, whereas for
smaller tumours (<4cm), only 14/22 (64%) had the S frag-
ment. On the other hand, nodal metastasis of the tumour was
not associated with a specific polymorphic fragment
(X2 = 0.0067, d.f. = 1, P = 0.9). On comparing L-myc RFLP
types with TNM staging (UICC, 1988), the more advanced
stages III and IV exhibited an increased proportion (55/
68 = 81%) of patients with S fragment compared with stages
I and II (5/8 = 63%). However, due to a small sample size of
stages I and II, a significant difference between these and the
advanced stages III and IV was not observed (X2 = 2.68,
d.f.=1, P=0.10).
Follow-up data for a 3-week period were available on 52
patients, 19 of whom had a recurrence of tumours in the oral
cavity within this period. Analysis of their RFLP pattern,
compared to the 33 patients showing no evidence of the
disease, did not show a significant correlation between the
RFLP pattern and recurrence of tumour in these patients
(x2 = 0.16, d.f. = 1, P = 0.69) (Table II).
.. 1 ,2 .3 4 -.6 6.. 7 8.9 10 11 I1 2 13.
'The RFLP pattern and allele frequencies in the PBC ofthe oral cancer
patients was identical to the corresponding tumour tissues. bFigures in
parentheses are percentages ofthe total recorded genotypes. cObserved
allele frequencies consistent with the Hardy-Weinberg law.532 D. SARANATH et al.
Table II Correlation of L-myc RFLP with clinical pattern of oral
cancers
Clinical pattern L-L L-S S-S
(no. ofpatients) (S-) (S+) pa
Grade of differentiation
Well (25) (25) 13 10 2 <0001
Poor-Mod. (51) 3 27 21
Nodal metastasis
N- (22) 4 11 7 0.9
N + (54) 12 26 16
Tumour size
4 cm (22) 8 10 4 <0.025
4cm (54) 8 27 19
TNM stages
I +11 (8) 3 4 1 0.102
III+IV (68) 13 33 22
Recurrenceb
R- (33) 8 19 6 0.69
R (19) 3 7 .
ap value with I d.f. (Yates' correction applied) in testing relative
frequencies oftumourswith orwithout the S fragment. bFollow-up data
for a period of 3 years was available on 52 patients.
Discussion
RFLPs are a consequence of single nucleotide substitutions
or insertion or deletion of a DNA segment in a genomic
sequence (Botstein et al., 1980). One of the purposes of
RFLP studies in cancer has been to establish a specific
association of a particular proto-oncogene RFLP, with in-
creased incidence of certain types of cancer, suggesting
genetic predisposition (Krontiris et al., 1985; Heighway et al.,
1986; Liderau et al., 1985, 1986; Kawashima et al., 1988;
Kakehi & Yoshida, 1989). Krontiris et al. (1985) surveyed
Ha-ras RFLP in leucocyte DNA of patients with several
types of cancer and of normal individuals. The authors
observed a high incidence of rare alleles in patients with
myelodysplasia and familial melanomas. Liderau et al. (1986)
and Honda et al. (1988) also found a higher frequency of
rare Ha-ras alleles in breast cancer patients than in normal
individuals. An allelic EcoRI restriciton fragment of the mos
oncogene has also been associated with breast cancer patients
(Liderau et al., 1985). On the other hand, in urothelial
cancers (Ishikawa et al., 1988) and colon adenocarcinomas
(Ceccherini-Nelli et al., 1987), prevalence of specific Ha-ras
polymorphic variants was not observed.
To investigate the status of L-myc RFLP fragments in
squamous cell carcinoma of the oral cavity, we examined
DNAs from the primary oral tumour tissues by Southern
analysis. We observed a correlation between the presence of
the S fragment either as S-S type or L-S type, and a poor to
moderate level of differentiation of the tumours, as well as
the large size of the tumours. An increased prevalence of the
S fragment in the advanced stages III and IV of the oral
cancers was also noticed. However, the number of patients in
stages I and II was small (eight), and hence a statistically
significant difference could not be seen on analysis. No cor-
relation with either L or S fragment and nodal metastasis or
recurrence of the malignancy was observed.
The polymorphic pattern in the PBC of the oral cancer
patients was identical to that in the tumour tissue, showing
no loss of alleles in the tumours. A preponderance of the
L-L, L-S or S-S fragments was not observed in the oral
cancer patients compared to normal healthy individuals.
Thus, presence of a particular allele did not indicate predis-
position to oral cancer. However, our results showed that
oral cancer patients with a genotype including an S fragment
are more likely to develop a poor to moderately
differentiated tumour or a larger tumour than patients with-
out an S fragment. The three reports of L-myc RFLP men-
tioned earlier were in the Japanese population (Kawashima
et al., 1988; Kakehi & Yoshida, 1989; Ikeda et al., 1988). An
analysis of the genotype distribution and the allelic frequen-
cies from their combined data indicates a similar L-myc
haplotype and allelic distribution pattern to that seen in the
Indian population.
Recently, Kakehi and Yoshida (1989) observed a correla-
tion between the presence of the S fragment of the L-myc
RFLP in renal cell carcinoma and the metastatic potential of
these tumours. Earlier Kawashima et al. (1987) had demon-
strated an association between the S fragment of L-myc and
metastasis to the nodes and distant organs in lung cancer.
Our results did not show a correlation of L-myc RFLP with
nodal metastasis. However, a close correlation with the stage
of differentiation of the tumours and the L-myc RFLP was
observed. In contrast Kakehi and Yoshida (1989), in renal
cancers, and Kawashima et al. (1988), in lung cancers, did
not observe such an association with the grade of tumour cell
differentiation. An interesting question is how the presence of
the S allele of L-myc could be related to the stage of
differentiation selectively in oral cancers. Kawashima et al.
(1988) have suggested possible explanations for the increased
presence of one of the alleles of L-myc (S fragment) in lung
tumours with greater potential for metastasis. They have
suggested a direct role for another gene closely asociated to
L-myc, a role for a partially different S-fragment-coded L-
myc protein, or a crucial role for the regulatory region of
L-myc S fragment protein in metastasis. These possibilities
could also hold true for the association of the S fragment
with the stage of differentiation in oral cancers. However, the
biological function of the L-myc protein and the complete
nucleotide sequence of both the alleles are needed to
elucidate the role of the L-myc S fragment in cancer.
The authors wish to thank Mrs Perin Notani for her advice in
statistical analysis of the data, Prof. George Klein for the probe and
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